Selected research
Industry Research
Bioinformatics Analysis Platforms Industry Research Report 2026
Market perspective
The global Bioinformatics Analysis Platforms market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioinformatics Analysis Platforms market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioinformatics Analysis Platforms market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioinformatics Analysis Platforms market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioinformatics Analysis Platforms include Illumina, Cellecta, Creative Biolabs, CD Genomics, Eurofins Genomics, CosmosID, Fios Genomics, GENEWIZ and Nuvisan, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioinformatics Analysis Platforms market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioinformatics Analysis Platforms.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioinformatics Analysis Platforms Market by Company
Illumina
Cellecta
Creative Biolabs
CD Genomics
Eurofins Genomics
CosmosID
Fios Genomics
GENEWIZ
Nuvisan
Lexogen
Epistem
Huace Testing and Certification
SHANGHAI BIOCHIP
Hangzhou Guangkeande Biotechnology
Tencent Healthcare
Guangzhou Geneseed Biotech
Shanghai Labway Clinical
Shanghai Biotechnology
Shanghai Bojie Medical
Shanghai Dunhui Medical
SangerBox
Zhenhe Biotechnology
Westlake Omics
Bioinformatics Analysis Platforms Segment by Type
Genomic Data Analysis
Transcriptomic Data Analysis
Epigenomic Data Analysis
Long-Read Sequencing Data Analysis
Bioinformatics Analysis Platforms Segment by Application
Scientific Research
Pharmaceuticals
Medical
Agriculture
Others
Bioinformatics Analysis Platforms Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioinformatics Analysis Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioinformatics Analysis Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioinformatics Analysis Platforms.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioinformatics Analysis Platforms companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genomic Data Analysis
- Transcriptomic Data Analysis
- Epigenomic Data Analysis
- Long-Read Sequencing Data Analysis
Applications
- Scientific Research
- Pharmaceuticals
- Medical
- Agriculture
- Others
Companies covered
- Illumina
- Cellecta
- Creative Biolabs
- CD Genomics
- Eurofins Genomics
- CosmosID
- Fios Genomics
- GENEWIZ
- Nuvisan
- Lexogen
- Epistem
- Huace Testing and Certification
- SHANGHAI BIOCHIP
- Hangzhou Guangkeande Biotechnology
- Tencent Healthcare
- Guangzhou Geneseed Biotech
- Shanghai Labway Clinical
- Shanghai Biotechnology
- Shanghai Bojie Medical
- Shanghai Dunhui Medical
- SangerBox
- Zhenhe Biotechnology
- Westlake Omics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioinformatics Analysis Platforms by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Genomic Data Analysis
- 2.2.3 Transcriptomic Data Analysis
- 2.2.4 Epigenomic Data Analysis
- 2.2.5 Long-Read Sequencing Data Analysis
- 2.3 Bioinformatics Analysis Platforms by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Scientific Research
- 2.3.3 Pharmaceuticals
- 2.3.4 Medical
- 2.3.5 Agriculture
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Bioinformatics Analysis Platforms Breakdown Data by Type
- 3.1 Global Bioinformatics Analysis Platforms Historic Market Size by Type (2021-2026)
- 3.2 Global Bioinformatics Analysis Platforms Forecasted Market Size by Type (2027-2032)
4 Bioinformatics Analysis Platforms Breakdown Data by Application
- 4.1 Global Bioinformatics Analysis Platforms Historic Market Size by Application (2021-2026)
- 4.2 Global Bioinformatics Analysis Platforms Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioinformatics Analysis Platforms Market Perspective (2021-2032)
- 5.2 Global Bioinformatics Analysis Platforms Growth Trends by Region
- 5.2.1 Global Bioinformatics Analysis Platforms Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioinformatics Analysis Platforms Historic Market Size by Region (2021-2026)
- 5.2.3 Bioinformatics Analysis Platforms Forecasted Market Size by Region (2027-2032)
- 5.3 Bioinformatics Analysis Platforms Market Dynamics
- 5.3.1 Bioinformatics Analysis Platforms Industry Trends
- 5.3.2 Bioinformatics Analysis Platforms Market Drivers
- 5.3.3 Bioinformatics Analysis Platforms Market Challenges
- 5.3.4 Bioinformatics Analysis Platforms Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioinformatics Analysis Platforms Players by Revenue
- 6.1.1 Global Top Bioinformatics Analysis Platforms Players by Revenue (2021-2026)
- 6.1.2 Global Bioinformatics Analysis Platforms Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioinformatics Analysis Platforms Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioinformatics Analysis Platforms Head Office and Area Served
- 6.4 Global Bioinformatics Analysis Platforms Players, Product Type & Application
- 6.5 Global Bioinformatics Analysis Platforms Manufacturers Established Date
- 6.6 Global Bioinformatics Analysis Platforms Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioinformatics Analysis Platforms Market Size (2021-2032)
- 7.2 North America Bioinformatics Analysis Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioinformatics Analysis Platforms Market Size by Country (2021-2026)
- 7.4 North America Bioinformatics Analysis Platforms Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioinformatics Analysis Platforms Market Size (2021-2032)
- 8.2 Europe Bioinformatics Analysis Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioinformatics Analysis Platforms Market Size by Country (2021-2026)
- 8.4 Europe Bioinformatics Analysis Platforms Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioinformatics Analysis Platforms Market Size (2021-2032)
- 9.2 Asia-Pacific Bioinformatics Analysis Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioinformatics Analysis Platforms Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioinformatics Analysis Platforms Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioinformatics Analysis Platforms Market Size (2021-2032)
- 10.2 South America Bioinformatics Analysis Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioinformatics Analysis Platforms Market Size by Country (2021-2026)
- 10.4 South America Bioinformatics Analysis Platforms Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioinformatics Analysis Platforms Market Size (2021-2032)
- 11.2 Middle East & Africa Bioinformatics Analysis Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioinformatics Analysis Platforms Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioinformatics Analysis Platforms Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.1.4 Illumina Bioinformatics Analysis Platforms Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Cellecta
- 12.2.1 Cellecta Company Information
- 12.2.2 Cellecta Business Overview
- 12.2.3 Cellecta Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.2.4 Cellecta Bioinformatics Analysis Platforms Product Portfolio
- 12.2.5 Cellecta Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.3.4 Creative Biolabs Bioinformatics Analysis Platforms Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 CD Genomics
- 12.4.1 CD Genomics Company Information
- 12.4.2 CD Genomics Business Overview
- 12.4.3 CD Genomics Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.4.4 CD Genomics Bioinformatics Analysis Platforms Product Portfolio
- 12.4.5 CD Genomics Recent Developments
- 12.5 Eurofins Genomics
- 12.5.1 Eurofins Genomics Company Information
- 12.5.2 Eurofins Genomics Business Overview
- 12.5.3 Eurofins Genomics Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.5.4 Eurofins Genomics Bioinformatics Analysis Platforms Product Portfolio
- 12.5.5 Eurofins Genomics Recent Developments
- 12.6 CosmosID
- 12.6.1 CosmosID Company Information
- 12.6.2 CosmosID Business Overview
- 12.6.3 CosmosID Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.6.4 CosmosID Bioinformatics Analysis Platforms Product Portfolio
- 12.6.5 CosmosID Recent Developments
- 12.7 Fios Genomics
- 12.7.1 Fios Genomics Company Information
- 12.7.2 Fios Genomics Business Overview
- 12.7.3 Fios Genomics Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.7.4 Fios Genomics Bioinformatics Analysis Platforms Product Portfolio
- 12.7.5 Fios Genomics Recent Developments
- 12.8 GENEWIZ
- 12.8.1 GENEWIZ Company Information
- 12.8.2 GENEWIZ Business Overview
- 12.8.3 GENEWIZ Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.8.4 GENEWIZ Bioinformatics Analysis Platforms Product Portfolio
- 12.8.5 GENEWIZ Recent Developments
- 12.9 Nuvisan
- 12.9.1 Nuvisan Company Information
- 12.9.2 Nuvisan Business Overview
- 12.9.3 Nuvisan Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.9.4 Nuvisan Bioinformatics Analysis Platforms Product Portfolio
- 12.9.5 Nuvisan Recent Developments
- 12.10 Lexogen
- 12.10.1 Lexogen Company Information
- 12.10.2 Lexogen Business Overview
- 12.10.3 Lexogen Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.10.4 Lexogen Bioinformatics Analysis Platforms Product Portfolio
- 12.10.5 Lexogen Recent Developments
- 12.11 Epistem
- 12.11.1 Epistem Company Information
- 12.11.2 Epistem Business Overview
- 12.11.3 Epistem Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.11.4 Epistem Bioinformatics Analysis Platforms Product Portfolio
- 12.11.5 Epistem Recent Developments
- 12.12 Huace Testing and Certification
- 12.12.1 Huace Testing and Certification Company Information
- 12.12.2 Huace Testing and Certification Business Overview
- 12.12.3 Huace Testing and Certification Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.12.4 Huace Testing and Certification Bioinformatics Analysis Platforms Product Portfolio
- 12.12.5 Huace Testing and Certification Recent Developments
- 12.13 SHANGHAI BIOCHIP
- 12.13.1 SHANGHAI BIOCHIP Company Information
- 12.13.2 SHANGHAI BIOCHIP Business Overview
- 12.13.3 SHANGHAI BIOCHIP Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.13.4 SHANGHAI BIOCHIP Bioinformatics Analysis Platforms Product Portfolio
- 12.13.5 SHANGHAI BIOCHIP Recent Developments
- 12.14 Hangzhou Guangkeande Biotechnology
- 12.14.1 Hangzhou Guangkeande Biotechnology Company Information
- 12.14.2 Hangzhou Guangkeande Biotechnology Business Overview
- 12.14.3 Hangzhou Guangkeande Biotechnology Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.14.4 Hangzhou Guangkeande Biotechnology Bioinformatics Analysis Platforms Product Portfolio
- 12.14.5 Hangzhou Guangkeande Biotechnology Recent Developments
- 12.15 Tencent Healthcare
- 12.15.1 Tencent Healthcare Company Information
- 12.15.2 Tencent Healthcare Business Overview
- 12.15.3 Tencent Healthcare Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.15.4 Tencent Healthcare Bioinformatics Analysis Platforms Product Portfolio
- 12.15.5 Tencent Healthcare Recent Developments
- 12.16 Guangzhou Geneseed Biotech
- 12.16.1 Guangzhou Geneseed Biotech Company Information
- 12.16.2 Guangzhou Geneseed Biotech Business Overview
- 12.16.3 Guangzhou Geneseed Biotech Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.16.4 Guangzhou Geneseed Biotech Bioinformatics Analysis Platforms Product Portfolio
- 12.16.5 Guangzhou Geneseed Biotech Recent Developments
- 12.17 Shanghai Labway Clinical
- 12.17.1 Shanghai Labway Clinical Company Information
- 12.17.2 Shanghai Labway Clinical Business Overview
- 12.17.3 Shanghai Labway Clinical Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.17.4 Shanghai Labway Clinical Bioinformatics Analysis Platforms Product Portfolio
- 12.17.5 Shanghai Labway Clinical Recent Developments
- 12.18 Shanghai Biotechnology
- 12.18.1 Shanghai Biotechnology Company Information
- 12.18.2 Shanghai Biotechnology Business Overview
- 12.18.3 Shanghai Biotechnology Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.18.4 Shanghai Biotechnology Bioinformatics Analysis Platforms Product Portfolio
- 12.18.5 Shanghai Biotechnology Recent Developments
- 12.19 Shanghai Bojie Medical
- 12.19.1 Shanghai Bojie Medical Company Information
- 12.19.2 Shanghai Bojie Medical Business Overview
- 12.19.3 Shanghai Bojie Medical Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.19.4 Shanghai Bojie Medical Bioinformatics Analysis Platforms Product Portfolio
- 12.19.5 Shanghai Bojie Medical Recent Developments
- 12.20 Shanghai Dunhui Medical
- 12.20.1 Shanghai Dunhui Medical Company Information
- 12.20.2 Shanghai Dunhui Medical Business Overview
- 12.20.3 Shanghai Dunhui Medical Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.20.4 Shanghai Dunhui Medical Bioinformatics Analysis Platforms Product Portfolio
- 12.20.5 Shanghai Dunhui Medical Recent Developments
- 12.21 SangerBox
- 12.21.1 SangerBox Company Information
- 12.21.2 SangerBox Business Overview
- 12.21.3 SangerBox Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.21.4 SangerBox Bioinformatics Analysis Platforms Product Portfolio
- 12.21.5 SangerBox Recent Developments
- 12.22 Zhenhe Biotechnology
- 12.22.1 Zhenhe Biotechnology Company Information
- 12.22.2 Zhenhe Biotechnology Business Overview
- 12.22.3 Zhenhe Biotechnology Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.22.4 Zhenhe Biotechnology Bioinformatics Analysis Platforms Product Portfolio
- 12.22.5 Zhenhe Biotechnology Recent Developments
- 12.23 Westlake Omics
- 12.23.1 Westlake Omics Company Information
- 12.23.2 Westlake Omics Business Overview
- 12.23.3 Westlake Omics Revenue in Bioinformatics Analysis Platforms Business (2021-2026)
- 12.23.4 Westlake Omics Bioinformatics Analysis Platforms Product Portfolio
- 12.23.5 Westlake Omics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst